Home » FDA OKs Drug for Rare Lipid Disorder
FDA OKs Drug for Rare Lipid Disorder
The FDA has approved the lipid-lowering drug lomitapide (Juxtapid) as add-on therapy in patients with a rare lipid disorder, the agency said.
MedPage Today
MedPage Today
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May